Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, ...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 0.0% | ||
| P/E Ratio | -26.5x | ||
| Revenue | 3.368 M | ||
| Net Income to Company | -799 K |
| CC5 | Peers | Sector | |
|---|---|---|---|
Market Cap | 21.189 M | 27.071 M | 98.658 M |
Price % of 52 Week High | 46.2% | 46.7% | 59.8% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | -8.5% | -14.9% | -0.7% |
1 Year Price Total Return | -40.0% | -25.0% | -12.5% |
Beta (5 Year) | 1.72 | 0.70 | 0.64 |
No data available
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Jun-23 | Jun-24 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 2.13 | 1.26 | 3.37 | 0.36 | 1.41 |
| Operating Income | (7.14) | (4.74) | (2.96) | (1.02) | (0.13) |
| Net Profit | (23) | (3.74) | (0.80) | (0.92) | 0.55 |
| Diluted EPS | -0.068 | -0.0040 | -0.00056 | -0.0016 | 0.00025 |
| EBITDA | (7.10) | (4.71) | (2.89) | (0.96) | (0.06) |
| Balance Sheet | |||||
| Cash & ST Invest. | 2.02 | 2.35 | 1.70 | 3.24 | 1.70 |
| Current Assets | 4.84 | 5.52 | 6.67 | 5.65 | 6.67 |
| Total Assets | 7.37 | 7.93 | 10 | 8.13 | 10 |
| Current Liabilities | 4.19 | 1.53 | 2.71 | 1.25 | 2.71 |
| Total Liabilities | 7.47 | 5.51 | 5.71 | 5.57 | 5.71 |
| Total Equity | (0.10) | 2.42 | 4.77 | 2.55 | 4.77 |
| Total Debt | 3.39 | 3.19 | 2.45 | 3.29 | 2.45 |
| Cash Flow Statement | |||||
| Cash Flow Operations | (1.40) | (3.67) | (2.03) | (0.67) | 0.15 |
| Cash From Investing | (0.30) | (0.01) | (1.13) | 0.00 | (0.56) |
| Cash From Financing | 0.94 | 4.01 | 1.61 | 1.28 | 0.09 |
| Free Cash Flow | (1.40) | (3.68) | (2.04) | (0.67) | 0.15 |